oxycodone has been researched along with Multiple Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diaz, CJ; Goode, PA; Leonard, JB; Nair, V; Penoyar, JB | 1 |
Cheung, SW; Joffe, RT; Otton, SV; Sellers, EM; Wu, D | 1 |
2 other study(ies) available for oxycodone and Multiple Sclerosis
Article | Year |
---|---|
Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use.
Topics: Aged; Analgesics, Opioid; Disabled Persons; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Multiple Sclerosis; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pressure Ulcer; Treatment Outcome | 2017 |
Inhibition by fluoxetine of cytochrome P450 2D6 activity.
Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Drug Interactions; Fluoxetine; Humans; In Vitro Techniques; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Multiple Sclerosis; Oxidation-Reduction; Oxycodone; Phenotype; Selective Serotonin Reuptake Inhibitors | 1993 |